Company intelligence / Profile preview

BENEV

Mission Viejo, California, United Statesbenev.com ↗

Ownership: Private
Development stage: Other

Overview

BENEV has a portfolio of FDA-cleared/commercially available products for skin and hair rejuvenation. Its exosome-based topicals are used post-procedure for enhanced recovery and visible results. The company also distributes Letybo, an FDA-approved botulinum toxin product for glabellar lines through a partnership with Hugel Inc.

Therapeutic areas: Dermatology
Modalities: Exosome-based therapySmall molecule (topical solutions)Device (medical aesthetic devices, e.g., microneedling, PDO threads)
Industry: Biotech

Partnerships

Hugel Inc. (for commercialization of Letybo in the U.S.)

Beyond the preview

Go deeper on BENEV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BENEV.

Explore the full profile